小鼠抗CA19-9单克隆抗体

Background:

CA 19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. CA 19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. Apart from cancer, elevated levels may also occur in pancreatitis, cirrhosis, and diseases of the bile ducts. It can be elevated in people with obstruction of the bile ducts.

Applications:

IHC

Name of antibody:

CA19-9

Immunogen:

SW1116 human colon carcinoma cell line

Full name:

CA19-9

IHC positive control:

carcinoma of human lung tissue and carcinoma of human bladder tissue

IHC Recommend dilution:

30-150